Mr. Maselli has held a range of leadership positions at Catalent over the past fourteen years, progressing from director of operations at a health and personal care plant in Italy, through general manager of operations in the U.K., vice president of operations for drug delivery solutions in Europe, senior vice president of global operations, and president and chief operating officer, before his appointment as president and CEO in 2022. He previously held leadership roles at Alstrom SA, SGS SA, and ABB Group ...

I don't usually like to touch on taxes, because each person's tax situation is extremely unique. The best way to get proper tax advice is to sit down with a registered tax professional whoHigh Dividend Opportunities, #1 On Seeking AlphaSave yourself thousands of dollars by creating a portfolio that pays you to hold it. No selling required to fund your retirement dreams. Tired of going it alone or visiting a financial advisor who just doesn't seem to care? Join our lively group! Our Income Method generates s ...

Target Corporation NYSE: TGT is struggling in 2025 and will take time for a sustained turnaround. However, its business remains profitable and a turnaround is likely, making it a deep-value, high-yielding retail stock trading at a generational low. Here’s a look at five reasons why now is a good time to buy it.  Get Target alerts:Target: The Technicals Indicate the Bottom Is In Target TodayTGTTarget$93.01 -5.11 (-5.21%) 52-Week Range$87.35▼$167.40Dividend Yield4.82%P/E Ratio9.86Price Target$127.29Add to Wa ...

JENA, Germany, May 22, 2025 (GLOBE NEWSWIRE) -- InflaRx N.V. (Nasdaq: IFRX), a biopharmaceutical company pioneering anti-inflammatory therapeutics by targeting the complement system, today announced that the Company will participate in multiple investor conferences in June and July 2025. Jefferies Global Healthcare ConferenceJune 3 - 5, 2025 in New York, NY InflaRx will conduct an investor presentation on June 4th at 7:35 AM ET and will participate in one-on-one investor meetings. A link to register for the ...

Study CL-QRX003-002 will test whole-body application of QRX003 in conjunction with off-label systemic therapy in approximately 12-15 subjects.Study CL-QRX003-002 complements first whole-body pivotal study, CL-QRX003-003, being led by Dr. Amy Paller at Northwestern University and supported by up to six international sites that are expected to open, where subjects are being tested with QRX003 as monotherapy. Combined data from Studies CL-QRX003-002 and CL-QRX003-003 is anticipated to provide QRX003 with the b ...

Join iREIT on Alpha today to get the most in-depth research that includes REITs, mREITs, Preferreds, BDCs, MLPs, ETFs, and other income alternatives. 438 testimonials and most are 5 stars. Nothing to lose with our FREE 2-week trial .The chart below was retrieved from John Authers' article titled "Moody's Blues Comes for U.S. Sentiment," which was obviously about theAnalyst’s Disclosure: I/we have a beneficial long position in the shares of PEP either through stock ownership, options, or other derivatives. I ...

VANCOUVER, British Columbia, May 22, 2025 (GLOBE NEWSWIRE) -- Almaden Minerals Ltd. (“Almaden” or “the Company”; TSX: AMM; OTCQB: AAUAF) announces that it has notified Almadex Minerals Ltd. (“Almadex”) of the early repayment of the outstanding gold loan pursuant to the secured gold loan agreement, as amended (“Gold Loan”), between Almaden and Almadex (see press releases dated June 27, 2024 and May 14, 2019). Under the terms of the Gold Loan, the “Gold Loan Value” was fixed as of May 13, 2025 and the outstan ...

Medicus Pharma Ltd Receives Study May Proceed Approval from United Arab Emirates (UAE) Department of Health (DOH) to Commence Phase 2 Clinical Study (SKNJCT-004) to Non-Invasively Treat Basal Cell Carcinoma of the Skin (BCC)The Clinical Study Is Expected to Randomize 36 Participants in Cleveland Clinic Abu Dhabi (CCAD) and Three Other Clinical Sites in UAEMay 22, 2025 7:30 AM EDT | Source: Medicus Pharma Ltd.Philadelphia, Pennsylvania--(Newsfile Corp. - May 22, 2025) - Medicus Pharma Ltd. (NAS ...

VANCOUVER, British Columbia, May 22, 2025 (GLOBE NEWSWIRE) -- Almadex Minerals Ltd. (“Almadex” or the “Company”) (TSX-V: “DEX”) announces that Almaden Minerals Ltd. (“Almaden”) has notified the Company of the early repayment of the outstanding gold loan pursuant to the secured gold loan agreement, as amended (“Gold Loan”), between Almaden and the Company (see press releases dated June 27, 2024 and May 14, 2019). Under the terms of the Gold Loan, the “Gold Loan Value” was fixed as of May 13, 2025 and the out ...

SANTA PAULA, Calif., May 22, 2025 (GLOBE NEWSWIRE) -- Calavo Growers, Inc. (Nasdaq-GS: CVGW), a global leader in the processing and distribution of avocados, tomatoes, papayas, and guacamole, today announced that it plans to release financial results for the fiscal second quarter ended April 30, 2025, after the market closes on Monday, June 9, 2025. About Calavo Growers, Inc.Calavo Growers, Inc. (Nasdaq: CVGW) is a global leader in the processing and distribution of avocados, tomatoes, papayas and guacamole ...